Filter
5814
Filtered Results: 5814
Text search:
patient
outcome
Featured
Recommendations
550
New Publications
1410
Language
Document type
No document type
3312
Studies & Reports
933
Guidelines
824
Manuals
306
Strategic & Response Plan
181
Fact sheets
98
Training Material
92
Situation Updates
29
Resource Platforms
18
Online Courses
8
Infographics
7
Brochures
5
Dashboards/Maps
1
Countries / Regions
India
287
Global
216
Kenya
165
South Africa
159
Western and Central Europe
124
Ethiopia
119
Sierra Leone
118
Liberia
100
Nigeria
98
Uganda
98
Africa
94
Malawi
89
Tanzania
80
Nepal
77
Latin America and the Carribbean
76
Zambia
75
Rwanda
70
Ghana
65
Myanmar / Burma
62
Bangladesh
58
Eastern Europe
57
Namibia
53
Ukraine
52
Russia
47
Brazil
43
Philippines
38
Lesotho
38
Syria
37
Guinea
36
Cambodia
35
Asia
33
Indonesia
32
South–East Asia Region
32
Mozambique
31
Germany
30
Congo, Democratic Republic of
29
Zimbabwe
28
East and Southern Africa
27
West and Central Africa
27
Senegal
26
Botswana
23
Eastern Europe and Central Asia
21
South Sudan
19
Colombia
19
USA
18
Haiti
18
Cameroon
17
Middle East and North Africa
17
Burkina Faso
15
Pakistan
13
Benin
13
Eswatini/ Swaziland
13
Argentina
11
Chile
11
Western Pacific Region
11
Venezuela
11
Ecuador
10
Thailand
9
Yemen
9
Laos
9
Afghanistan
8
Peru
8
Angola
8
North America
8
Sri Lanka
7
Paraguay
7
Albania
7
Tajikistan
7
Georgia
7
Vietnam
7
Somalia
6
Jordan
6
Sudan
6
Southern Africa
6
United Kingdom
6
Iraq
5
Lebanon
5
China
5
Bolivia
5
Spain
5
Guinea-Bissau
4
Turkey
4
Gambia
4
Central African Republic
4
Jamaica
4
Mali
3
Côte d’Ivoire / Ivory Coast
3
Papua New Guinea
3
North Macedonia
3
Mexico
3
Palestine
3
Canada
3
Estonia
3
Moldova
3
Kyrgyzstan
3
Mauritius
3
Portugal
3
Morocco
2
Saudi Arabia
2
Togo
2
Egypt
2
Chad
2
Singapore
2
El Salvador
2
Guatemala
2
Other region
2
Bhutan
2
Armenia
2
Timor Leste/ East Timor
2
Iran
2
Kazakhstan
2
France
2
Mauritania
1
Ireland
1
Serbia
1
Hungary
1
Honduras
1
Greece
1
Libya
1
Madagascar
1
Solomon Islands
1
Italy
1
Congo-Brazzaville
1
Qatar
1
Bulgaria
1
Romania
1
Lithuania
1
Australia
1
Uruguay
1
Turkmenistan
1
Japan
1
Maldives
1
Tunisia
1
Norway
1
Latvia
1
Authors & Publishers
Publication Years
Category
Countries
2048
Clinical Guidelines
572
Public Health
372
Women & Child Health
244
Key Resources
173
Capacity Building
99
Pharmacy & Technologies
57
Toolboxes
Mental Health
590
HIV
506
TB
499
COVID-19
483
Caregiver
229
AMR
191
NCDs
177
Ebola
165
Rapid Response
159
NTDs
153
Disability
122
Pharmacy
115
Planetary Health
102
Conflict
98
Global Health Education
69
Refugee
67
Zika
37
Cholera
34
Social Ethics
29
Health Financing Toolbox
27
Polio
26
Natural Hazards
26
Specific Hazards
17
Health Financing
1
Antimicrobial resistance is a global threat as it is present in all parts of the world and it means that there is a shortage of effective antibiotics to treat simple infections and diseases, also statistics reveal that because of antimicrobial resistance p...’ morbidity and mortality is increased, as well as healthcare related expenditures. Theoretical frameworks chosen for this study are Mark Salmon White’s construct for public health nursing and Tannahill’s model for health promotion. Both models focus on promoting and contributing to the health and well-being of the public. In this thesis the nurse’s role is explored and steps that can be taken towards contributing to minimizing antimicrobial resistance are listed
The reader acknowledges that this report is intended as an evidence-based asthma management strategy, for the use of health professionals and policy-makers. It is based, to the best of our knowledge, on current best evidence and medical knowledge and practice at the date of publication. When assessi...
The objective of the 2022 Compendium is to compile and highlight emerging innovative health technologies for low-resource settings. It presents a snapshot of technologies that are solutions to an unmet medical/health technology need or are likely to improve health ...s and the quality of life. Health technologies in the Compendium underwent WHO evidence-based assessments focused on the life cycle of health technology innovations for low-resource settings.
This twelfth version of the WHO living guideline now contains 19 recommendations. This latest update provides updated recommendations for remdesivir, addresses the use of combination therapy with corticosteroids, interleukin-6 (IL-6) receptor blockers and Janus kinase (JAK) inhibitors in ... with severe or critical COVID-19, and modifies previous recommendations for the neutralizing monoclonal antibodies sotrovimab and casirivimab-imdevimab in patients with non-severe COVID-19.
WHO has updated its guidelines for COVID-19 therapeutics, with revised recommendations for patients with non-severe COVID-19. This is the 13th update to these guidelines.
Updated risk rates for hospital admission in ... with non-severe COVID-19
The guidance includes updated risk rates for hospital admission in patients with non-severe COVID-19.
The current COVID-19 virus variants tend to cause less severe disease while immunity levels are higher due to vaccination, leading to lower risks of severe illness and death for most patients.
This update includes new baseline risk estimates for hospital admission in patients with non-severe COVID-19. The new ‘moderate risk’ category now includes people previously considered to be high risk including older people and/or those with chronic conditions, disabilities, and comorbidities of chronic disease. The updated risk estimates will assist healthcare professionals to identify individuals at high, moderate or low risk of hospital admission, and to tailor treatment according to WHO guidelines:
**High: **People who are immunosuppressed remain at higher risk if they contract COVID-19, with an estimated hospitalization rate of 6%.
**Moderate: **People over 65 years old, those with conditions like obesity, diabetes and/or chronic conditions including chronic obstructive pulmonary disease, kidney or liver disease, cancer, people with disabilities and those with comorbidities of chronic disease are at moderate risk, with an estimated hospitalization rate of 3%.
Low: Those who are not in the high or moderate risk categories are at low risk of hospitalization (0.5%). Most people are low risk.
Review of COVID-19 treatments for people with non-severe COVID-19
WHO continues to strongly recommend nirmatrelvir-ritonavir (also known by its brand name ‘Paxlovid’) for people at high-risk and moderate risk of hospitalization. The recommendations state that nirmatrelvir-ritonavir is considered the best choice for most eligible patients, given its therapeutic benefits, ease of administration and fewer concerns about potential harms. Nirmatrelvir-ritonavir was first recommended by WHO in April 2022.
If nirmatrelvir-ritonavir is not available to patients at high-risk of hospitalization, WHO suggests the use of molnupiravir or remdesivir instead.
WHO suggests against the use of molnupiravir and remdesivir for patients at moderate risk, judging the potential harms to outweigh the limited benefits in patients at moderate risk of hospital admission.
For people at low risk of hospitalization, WHO does not recommend any antiviral therapy. Symptoms like fever and pain can continue to be managed with analgesics like paracetamol.
WHO also recommends against use of a new antiviral (VV116) for patients, except in clinical trials.
The update also includes a strong recommendation against the use of ivermectin for patients with non-severe COVID-19. WHO continues to advise that in patients with severe or critical COVID-19, ivermectin should only be used in clinical trials.
Asthma is the most common chronic condition in children worldwide. It affects daytime activities, sleep and school attendance and causes anxiety to parents, families and other carers. The quality of asthma diagnosis and management globally still needs substantial improvement. From infancy to the tee...
Q 10: In adults and children with epilepsy, which psychological interventions used as adjunctive therapies with antiepileptic drugs when compared to placebo/comparator produce benefits/harm in specified outcomes?
These policy guidelines provide a strategic approach and new recommendations for integrated TB and HIV services for patients suffering from substance-abuse addiction. The key recommendations fall under three main categories: joint planning, key inte...
The main aim of this assessment was to evaluate the PSS response of URCS to these VHF, against the needs of beneficiaries and communities focused on the areas of most ‘added value’ of the URCS; community engagement mobilisation and support, documenting any unintended ...s and best practice related to the operation.
This guide is a resource for physicians and other health care professionals who provide care and treatment to patients with drug-resistant tuberculosis.
Skin and mucosal conditions are extremely common in all children and adults in particular in HIV-infected adults and children and are one of the commonest daily management problems faced by health care workers caring for patients with HIV infection
The scope of this PPC document is to serve as a guide to address the unmet public health need for a PPE system that protects the HW-F in tropical climate
s while caring for patients and providing heavy duty essential health services.
The charact...
The mandate of the National Tuberculosis Control Programme is to provide leadership and stewardship to accelerate intense and coordinated efforts to reduce the adult TB burden of 290 per 100,000 population recently established in the 2013 National TB Prevalence Survey. Other key challenges are low T...
The National Strategic Plan is based on the following guiding principles:
1) Life-course approach: adolescence is a key decade in the course of life that influences the health outcomes later in life.
2) Comprehensive approach: It recogniz...
1) Life-course approach: adolescence is a key decade in the course of life that influences the health outcomes later in life.
2) Comprehensive approach: It recogniz...
The purpose of this manual is to provide guidance in the design, implementation and evaluation of a course that aims to build and strengthen the capacity of health personnel to manage eye patients at primary-level health facilities in the African Re...
This treatment guideline is intended to assist clinicians in the Behavioral Health department in treatment planning and service delivery for patients with Post Traumatic Stress Disorder (PTSD). It may also assist clinicians treating ... who have some of the signs and symptoms of PTSD but who do not meet the full criteria of PTSD. The treatment guideline is not intended to cover every aspect of clinical practice, but to focus specifically on the treatment models and modalities that clinicians in our outpatient treatment setting could provide. These guidelines were developed through a process of literature review and discussion amongst clinicians in the Behavioral Health department and represent a consensus recommendation for service provision for this disorder. The guideline is intended to inform both clinical and administrative practices with the explicit goals of outlining treatment that is: effective, efficient, culturally relevant and acceptable to clinicians, program managers, and patients.
Q9: For carers of people with dementia, do interventions (psychoeducational, cognitive-behavioural therapy counseling/case management, general support, training of caregivers, multi-component interventions and miscellaneous interventions) when compared to placebo/comparator, produce benefits/harm in...
The updated List of Essential Diagnostics contains 46 general tests that can be used for routine patient care as well as for the detection and diagnosis of a wide array of disease conditions, and 69 tests intended for the detection, diagnosis and mo...
This guide has been written to provide information and practical advice on developing and delivering local plans an strategies to commission the most effective and efficient older people’s mental health services.Based upon clinical best practice guidance and drawing upon the range of available evi...
Management of Diabetes Mellitus-Tuberculosis
recommended
1st edition
This resource provides practical guidance for front line health workers responsible for the diagnosis, management and care of patients with these two diseases. Published in collaboration with the World Diabetes Foundation
